X0708 D LIVE 0001100397 Ayala Pharmaceuticals, Inc. 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 732 545 1590 DELAWARE None Advaxis, Inc. GREAT EXPECTATIONS & ASSOCIATES INC Corporation true Ken A. Berlin 9 Deer Park Drive, Suite K-1 Monmouth Junction NJ NEW JERSEY 08852 Director Executive Officer President, Chief Executive Officer and Director Roy Golan 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Executive Officer Chief Financial Officer Igor Gitelman 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Executive Officer SVP Finance and former Interim CFO Andres Gutierrez 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Executive Officer EVP and Chief Medical Officer David Sidransky 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Chair of Board Roni A. Appel 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Vered Bisker-Leib 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Yuval Cabilly 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Murray A. Goldberg 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Bridget Martell 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Pini Orbach 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Robert Spiegel 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Biotechnology Decline to Disclose 06b false 2023-10-18 false true true true Shares of common stock true Issuer completed merger where each outstanding target share was exchanged for 1.82285 Issuer common shares. Of shares issued, 466,479 were issued under 506(b) & the remainder under Reg S. 0 433825 433825 0 Amounts above based on $0.93 per share, the closing price of the common stock on OTCQX on date of merger. false 3 0 0 0 Ayala Pharmaceuticals, Inc. /s/ Ken A. Berlin Ken A. Berlin President and CEO 2023-11-02